Please login to the form below

Not currently logged in
Email:
Password:

insomnia

This page shows the latest insomnia news and features for those working in and with pharma, biotech and healthcare.

Sage raises $575m ahead of FDA review date for Zulresso

Sage raises $575m ahead of FDA review date for Zulresso

It is also in earlier-stage studies for MDD plus insomnia as a maintenance therapy for depression and bipolar disorder.

Latest news

More from news
Approximately 4 fully matching, plus 79 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics